Excerpts: a Sunday note from Morgan Stanley’s chief biotech analyst Matthew Harrison Welcome to your first and only chance to have a Morgan Stanley biotech analyst tell you what he thinks about the market. Over the past week it has been striking to see how investors have reacted to the first signs that new COVID-19 […]
Fenix Investors
Private Equity